Recently, a novel imaging modality, prostate-specific membrane antigen emission tomography (PSMA PET), has demonstrated potential as an adjunctive or alternative imaging technique for primary prostate cancer diagnosis [2]. The gene discussed is FOLH1; the disease is prostate cancer.